KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,755,070 | -39.4% | 126,264 | +0.2% | 0.00% | -100.0% |
| Q2 2023 | $2,898,027 | -89.9% | 126,056 | -87.0% | 0.00% | -83.3% |
| Q1 2023 | $28,621,615 | +15.8% | 965,967 | -2.4% | 0.01% | 0.0% |
| Q4 2022 | $24,709,551 | +10.7% | 989,966 | -3.4% | 0.01% | +20.0% |
| Q3 2022 | $22,318,000 | +10.6% | 1,025,244 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $20,175,000 | -30.5% | 1,024,662 | +49.3% | 0.01% | -16.7% |
| Q1 2022 | $29,041,000 | -13.8% | 686,194 | +29.3% | 0.01% | 0.0% |
| Q4 2021 | $33,696,000 | +14.5% | 530,718 | +6.0% | 0.01% | 0.0% |
| Q3 2021 | $29,422,000 | +784.6% | 500,880 | +630.4% | 0.01% | +500.0% |
| Q2 2021 | $3,326,000 | +123.4% | 68,580 | +78.9% | 0.00% | – |
| Q1 2021 | $1,489,000 | -40.3% | 38,336 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $2,496,000 | – | 40,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |